SWOT Analysis for HCW Biologics Inc

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
MACD crossed above signal line previous end of day
Stock gained more than 20% in one month
Increasing profits every quarter for the past 4 quarters
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter